Clinical Trial Update: Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered AB-101 in healthy volunteers and chronic hepatitis B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AB-101

Snippet

Sponsor: Arbutus Biopharma Corporation | Conditions: Chronic Hepatitis b | Phase 1 | Status: COMPLETED